Società AstraZeneca PLC

AZN

GB0009895292

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per AstraZeneca PLC

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - London S.E. Altri mercati azionari 17:35:09 26/04/2024			Variaz. 5gg	Var. 1 gen.
11.988 ^GBX	-0,32%		+9,52%	+13,09%

26/04	ASTRAZENECA : DZ Bank rimane Neutral	ZD
26/04	ASTRAZENECA : UBS ancora valutazione negativa	ZD

AstraZeneca PLC è uno dei gruppi farmaceutici leader a livello mondiale. Le vendite nette sono suddivise per fonte di reddito come segue:
- vendite di prodotti (95,6%). Le vendite nette sono suddivise per area di trattamento tra oncologia (39,2%), malattie cardiovascolari, renali e metaboliche (24,2%), malattie respiratorie e autoimmuni (13,9%) e altro (22,7%; malattie infiammatorie, neurologiche, gastrointestinali e infettive);
- ricavi da collaborazioni (4,4%).
Le vendite nette sono distribuite geograficamente come segue: Regno Unito (7,4%), Europa (21,2%), America (45,3%) e Africa-Asia-Australia (26,1%).

Numero di dipendenti: 89 900

GBP in Milioni	2022	Peso	2023	Peso	Delta
Oncology 37,4 %	11 878	33,0 %	13 793	37,4 %	+16,12%
Cardiovascular, Renal and Metabolism 23,1 %	7 459	20,7 %	8 515	23,1 %	+14,16%
Rare Disease 16,9 %	5 726	15,9 %	6 246	16,9 %	+9,08%
Respiratory and Immunology 13,3 %	4 680	13,0 %	4 913	13,3 %	+4,97%
Alliance 3,1 %	-	-	1 149	3,1 %	-
Other Medicines 2,6 %	1 319	3,7 %	946	2,6 %	-28,29%
Vaccines and Immune Therapies 2,2 %	3 845	10,7 %	814	2,2 %	-78,83%
Collaboration 1,3 %	1 098	3,1 %	478	1,3 %	-56,50%

GBP in Milioni	2022	Peso	2023	Peso	Delta
United States 39,6 %	14 027	39,0 %	14 578	39,6 %	+3,93%
China 12,8 %	4 662	12,9 %	4 724	12,8 %	+1,32%
Japan 7,9 %	3 236	9,0 %	2 928	7,9 %	-9,51%
United Kingdom 7,4 %	2 530	7,0 %	2 709	7,4 %	+7,07%
Other Rest of Europe 6,8 %	2 197	6,1 %	2 502	6,8 %	+13,89%
Germany 4,6 %	1 544	4,3 %	1 689	4,6 %	+9,36%
Other Asia, Africa and Australasia 4,5 %	1 953	5,4 %	1 645	4,5 %	-15,77%
Sweden 3,7 %	1 397	3,9 %	1 371	3,7 %	-1,89%
Other Americas 3,7 %	954	2,6 %	1 354	3,7 %	+41,94%
France 2,5 %	899	2,5 %	927	2,5 %	+3,12%
Canada 2,1 %	947	2,6 %	778	2,1 %	-17,82%
Spain 1,8 %	599	1,7 %	681	1,8 %	+13,73%
Italy 1,8 %	597	1,7 %	654	1,8 %	+9,61%
Australia 0,9 %	464	1,3 %	314	0,9 %	-32,32%

Dirigenti	Titolo	Età	Da
Pascal Soriot CEO	Chief Executive Officer	63	01/10/12
Aradhana Sarin DFI	Director of Finance/CFO	50	01/08/21
Cindy Hoots CTO	Chief Tech/Sci/R&D Officer	56	01/01/20
Sharon Barr CTO	Chief Tech/Sci/R&D Officer	-	01/08/23
Regina Danielson CTO	Chief Tech/Sci/R&D Officer	60	-
Alberto Hegewisch CTO	Chief Tech/Sci/R&D Officer	-	18/05/23
Pam Cheng COO	Chief Operating Officer	53	01/06/15
Jeffrey Pott CMP	Compliance Officer	-	01/01/95
Margareta Elisabeth Björk PRN	Corporate Officer/Principal	63	01/01/02
Iskra Reic PRN	Corporate Officer/Principal	-	01/01/01

Amministratori	Titolo	Età	Da
Sherilyn McCoy BRD	Director/Board Member	65	01/10/17
Ahmed Hamdy PRN	Corporate Officer/Principal	59	01/02/13
Philip Broadley BRD	Director/Board Member	63	27/04/17
Marcus Wallenberg BRD	Director/Board Member	68	01/04/99
Marc Dunoyer PRN	Corporate Officer/Principal	71	01/06/13
Andreas Rummelt BRD	Director/Board Member	66	01/08/21
Michel Demaré CHM	Chairman	67	01/09/19
Pascal Soriot CEO	Chief Executive Officer	63	01/10/12
Deborah DiSanzo BRD	Director/Board Member	64	01/12/17
Aradhana Sarin DFI	Director of Finance/CFO	50	01/08/21

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	1 550 162 626	1 495 897 151 ( 96,50 %)	0	96,50 %

Nome	Azioni	%	Valorizzazione
BlackRock Investment Management (UK) Ltd. 4,420 %	68 512 693	4,420 %	9 242 M p
Wellington Management Co. LLP 4,201 %	65 120 892	4,201 %	8 784 M p
The Vanguard Group, Inc. 3,669 %	56 870 000	3,669 %	7 671 M p
Investor AB (Investment Company) 3,328 %	51 587 810	3,328 %	6 959 M p
Norges Bank Investment Management 2,216 %	34 357 000	2,216 %	4 634 M p
BlackRock Fund Advisors 1,918 %	29 736 171	1,918 %	4 011 M p
BlackRock Advisors (UK) Ltd. 1,433 %	22 209 529	1,433 %	2 996 M p
Swedbank Robur Fonder AB 1,096 %	16 986 070	1,096 %	2 291 M p
SSgA Funds Management, Inc. 1,001 %	15 520 000	1,001 %	2 093 M p
Legal & General Investment Management Ltd. 0,9914 %	15 369 242	0,9914 %	2 073 M p

Nome	Azioni	%	Valorizzazione
T. Rowe Price International Ltd. 1,686 %	52 269 524	1,686 %	3 541 M p
Wellington Management Co. LLP 1,595 %	49 444 180	1,595 %	3 350 M p
PRIMECAP Management Co. 1,386 %	42 987 075	1,386 %	2 912 M p
Capital Research & Management Co. (International Investors) 1,122 %	34 782 762	1,122 %	2 357 M p
Fidelity Management & Research Co. LLC 0,6877 %	21 321 999	0,6877 %	1 445 M p
Jennison Associates LLC 0,5719 %	17 732 542	0,5719 %	1 201 M p
Sanders Capital LLC 0,4736 %	14 684 066	0,4736 %	995 M p
GQG Partners LLC 0,4470 %	13 858 383	0,4470 %	939 M p
Eaton Vance Management 0,4041 %	12 530 160	0,4041 %	849 M p
Merrill Lynch International 0,3772 %	11 695 224	0,3772 %	792 M p

Nome	Azioni	%	Valorizzazione
Caixa DTVM SA 0,002924 %	272 113	0,002924 %	3 M p

Nome	Azioni	%	Valorizzazione
ASTRAZENECA PHARMA INDIA LIMITED 75.00%	18 750 000	75.00%	1 196 097 188 $
SWEDISH ORPHAN BIOVITRUM AB 9.06%	32 100 518	9.06%	802 167 869 $
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 37.58%	108 923 023	37.58%	678 032 747 $
NIOX GROUP PLC 16.81%	71 065 878	16.81%	57 455 341 $
CELLECTIS S.A. 22.30%	16 000 000	22.30%	42 992 640 $
ADC THERAPEUTICS SA 4.86%	4 011 215	4.86%	18 010 355 $
INNATE PHARMA 9.26%	7 485 500	9.26%	17 664 283 $
PIERIS PHARMACEUTICALS, INC. 3.63%	3 584 230	3.63%	655 914 $
ARIDIS PHARMACEUTICALS, INC. 1.99%	884 956	1.99%	69 027 $

AstraZeneca PLC

Cambridge Biomedical Campus 1 Francis Crick Avenue

CB2 0AA, Cambridge

+44 20 3749 5000

http://www.astrazeneca.co.uk

Nome	Categoria e settore
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Miscellaneous Commercial Services
ASTRAZENECA PHARMA INDIA LIMITED	Pharmaceuticals: Major
AstraZeneca UK Ltd. AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.	Miscellaneous Commercial Services
R&Q Beta Co. Plc R&Q Beta Co. Plc Insurance Brokers/ServicesFinance R&Q Beta Co. Plc provides insurance services. The company was founded in 1994 and is headquartered in Cambridge, the United Kingdom.	Insurance Brokers/Services
AstraZeneca India Pvt Ltd. AstraZeneca India Pvt Ltd. Pharmaceuticals: MajorHealth Technology AstraZeneca India Pvt Ltd. operates as a biopharmaceutical company. The company was founded in 1979 and is headquartered in Bangalore, India.	Pharmaceuticals: Major
Astrazeneca Holdings BV
AstraZeneca Share Trust Ltd. AstraZeneca Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Share Trust Ltd. is a British company that provides business support services. The private company is located in the UK.	Miscellaneous Commercial Services
AstraZeneca Employee Share Trust Ltd. AstraZeneca Employee Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Employee Share Trust Ltd. is a British company that provides business support services. The private company is located in the UK.	Miscellaneous Commercial Services
Astrazeneca Treasury BV
Astrazeneca Finance & Holdings, Inc. Astrazeneca Finance & Holdings, Inc. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Finance & Holdings, Inc. is an investment holding American company. The private company is located in the US.	Financial Conglomerates
AstraZeneca Finance LLC	Finance/Rental/Leasing
Alexion Pharmaceuticals, Inc. /New/
Astrazeneca Treasury Ltd. Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK.	Financial Conglomerates

Rating Trading

Rating Investimento

ESG Refinitiv

B+

Altri rating

Vendita

Buy

Raccomandazione media

Buy

Numero di analisti

Ultimo prezzo di chiusura

149,3 USD

Prezzo obiettivo medio

164,4 USD

Differenza / Target Medio

+10,08%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
ASTRAZENECA PLC	+13,09%	231 Mrd
ELI LILLY AND COMPANY	+25,83%	661 Mrd
NOVO NORDISK A/S	+27,00%	566 Mrd
JOHNSON & JOHNSON	-6,76%	352 Mrd
MERCK & CO., INC.	+20,34%	332 Mrd
ABBVIE INC.	+3,00%	283 Mrd
NOVARTIS AG	+5,46%	200 Mrd
ROCHE HOLDING AG	-9,61%	195 Mrd
AMGEN INC.	-6,26%	145 Mrd
PFIZER, INC.	-11,77%	144 Mrd

Prodotti farmaceutici - Altri